NIDA Home > About NIDA > Organization   

Scientific Review Group/Committee Structure
gray line



Office of Extramural Affairs Grant and Contract Review Committees
Code Committee Name
or Description		 Scientific Review Officer Research Areas
NIDA/K Training and
Career Development		 Eliane Lazar-Wesley, Ph.D.
301-451-4530		 NIDA's remaining Institute-based standing review committee that reviews grant applications for career development and institutional training in research relevant to NIDA; will transition to CSR October, 2012.
ZDA1-___- Special Emphasis
Panels (SEP)		 Various NIDA SROs A NIDA Special Emphasis Panel (SEP) is recruited by the SRO for a special review, often a unique RFA or a Program Announcement (PA), or for contract proposals. Some recurring SEPreviewed at NIDA are listed below.
ZDA1-EXL-T Special Emphasis Panel (SEP) for NIDA Centers Eliane Lazar-Wesley, Ph.D.
301-451-4530
elazarwe@nida.nih.gov		 Review complex multidisciplinary, multi-component applications with administrative and scientific cores and projects related to an integrating theme.
ZDA1-___- Special Emphasis Panel (SEP) for assorted FOAs Various NIDA SROs Review applications involving multi-site clinical trials, Ętime-sensitive applications, R25 mechanisms, Avant Garde.
ZDA1-NXR-B Special Emphasis
Panel (SEP) for
Avant-Garde
RFA-DA-08-003		 Nadine Rogers, Ph.D.
301-402-2105
nadine.rogers@nih.gov
 Review grant applications designed by individual scientists of exceptional creativity who propose approaches at the forefront of drug abuse and HIV/AIDS research.
ZDA1-MXL-A Special Emphasis Panel (SEP) for
Conference Grants
PA-08-149		 Minna Liang, Ph.D.
301-435-1432
liangm@mail.nih.gov
 Review grant applications for high quality conferences/ scientific meetings relevant to NIDA's scientific and public health issues.
ZDA1-GXM-A Special Emphasis
Panel (SEP) for
B/START
PAR-09-239		 Gerald McLaughlin, Ph.D.
301-402-6626
gerald.mclaughlin@nih.gov
 Review grant applications to facilitate the entry of beginning investigators with behavioral science research relevant to drug abuse.
ZDA1-GXM-A Special Emphasis
Panel (SEP) for
I/START
PAR-06-311		 Gerald McLaughlin, Ph.D.
301-402-6626
gerald.mclaughlin@nih.gov
 Review grant applications to facilitate the entry of beginning investigators with brain imaging research relevant to drug abuse.
ZDA1-SXC-A Special Emphasis
Panel (SEP) for
CEBRA
PAR-06-209		 Scott Chen, Ph.D.
301-443-9511
chensc@mail.nih.gov
 Review grant applications to foster highly innovative or conceptually creative research related to drug abuse and addiction and how to prevent and treat them, and to support high-risk, potentially high-impact that is underrepresented or not included in NIDA's current portfolio.
*The standing review committees that reviewed the R mechanism, [NIDA/E (Treatment), NIDA/F (Health Services), and NIDA/L (Medication Development)], were dissolved in 2009, and most applications that would have been reviewed in these committees are now being reviewed in CSR.

Click here for rosters of review groups that are managed by the Center for Scientific Review or other Institutes.

For general committee information contact:

Ms. Camilla L. Holland,
NIDA Committee Management Officer
(301)435-1384.

For specific committee information contact the Scientific Review Officer listed above.

Office Address:

Office of Extramural Affairs
National Institute on Drug Abuse
National Institutes of Health
6001 Executive Boulevard
Room 4230, MSC 9550
Bethesda, Maryland 20892-9550

FAQ's for Grants and Contracts

About NIDA Contents